DE69417523T2 - 3-Oxo-1,4-Benzothiazinderivate - Google Patents

3-Oxo-1,4-Benzothiazinderivate

Info

Publication number
DE69417523T2
DE69417523T2 DE69417523T DE69417523T DE69417523T2 DE 69417523 T2 DE69417523 T2 DE 69417523T2 DE 69417523 T DE69417523 T DE 69417523T DE 69417523 T DE69417523 T DE 69417523T DE 69417523 T2 DE69417523 T2 DE 69417523T2
Authority
DE
Germany
Prior art keywords
compound
hydroxy
benzothiazine
oxo
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69417523T
Other languages
German (de)
English (en)
Other versions
DE69417523D1 (de
Inventor
Yoichi Kawashima
Hiroyuki Mibu
Yuko Morikawa
Atsuigaoka Ota
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of DE69417523D1 publication Critical patent/DE69417523D1/de
Application granted granted Critical
Publication of DE69417523T2 publication Critical patent/DE69417523T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6544—Six-membered rings
    • C07F9/6547—Six-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69417523T 1993-12-09 1994-12-05 3-Oxo-1,4-Benzothiazinderivate Expired - Fee Related DE69417523T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30913193 1993-12-09

Publications (2)

Publication Number Publication Date
DE69417523D1 DE69417523D1 (de) 1999-05-06
DE69417523T2 true DE69417523T2 (de) 1999-09-16

Family

ID=17989274

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69417523T Expired - Fee Related DE69417523T2 (de) 1993-12-09 1994-12-05 3-Oxo-1,4-Benzothiazinderivate

Country Status (10)

Country Link
US (1) US5547952A (enExample)
EP (1) EP0657444B1 (enExample)
KR (1) KR950017982A (enExample)
CN (1) CN1109882A (enExample)
AT (1) ATE178323T1 (enExample)
CA (1) CA2137626A1 (enExample)
DE (1) DE69417523T2 (enExample)
FI (1) FI945762A7 (enExample)
NO (1) NO944762L (enExample)
TW (1) TW306919B (enExample)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923709A (en) * 1974-08-30 1975-12-02 Monsanto Co 3,4-Dihydro-3-oxo-2H-1,4-benzothiazines and benzoxazines
US4078062A (en) * 1976-10-28 1978-03-07 E. R. Squibb & Sons, Inc. Substituted 2H-1,4-benzothiazin-3(4H)-ones
US4584300A (en) * 1983-02-07 1986-04-22 Santen Pharmaceutical Co., Ltd. Platelet anti-aggregative- and calcium antagonistic -1,4-benzothiazin-3-one derivatives, compositions, and methods of use therefor
GB8413915D0 (en) * 1984-05-31 1984-07-04 Wellcome Found Phenothiazine compounds
JPH0730058B2 (ja) * 1988-05-14 1995-04-05 参天製薬株式会社 ３−オキソ−１，４−ベンゾチアジン誘導体
WO1994005647A1 (fr) * 1992-08-31 1994-03-17 Santen Pharmaceutical Co., Ltd. Derive de 3-oxo-1,4-benzothiazine

Also Published As

Publication number Publication date
ATE178323T1 (de) 1999-04-15
FI945762L (fi) 1995-06-10
CA2137626A1 (en) 1995-06-10
DE69417523D1 (de) 1999-05-06
FI945762A7 (fi) 1995-06-10
FI945762A0 (fi) 1994-12-08
TW306919B (enExample) 1997-06-01
EP0657444B1 (en) 1999-03-31
EP0657444A1 (en) 1995-06-14
NO944762D0 (no) 1994-12-08
CN1109882A (zh) 1995-10-11
US5547952A (en) 1996-08-20
NO944762L (no) 1995-06-12
KR950017982A (ko) 1995-07-22

Similar Documents

Publication Publication Date Title
DE3884563T2 (de) Aminomethyl-oxo-oxazolidinyl-ethenylbenzen-Derivate, nützlich als antibakterielles Mittel.
EP0830863A1 (de) Die gastrointestinale Durchblutung fördernde Arzneimittel
DE69223827T2 (de) Glycyrrheticsäurederivate
DE69018876T2 (de) Pyridazinon-Derivate.
DE69218042T2 (de) Aromatische Amid-Verbindungen und ihre Herstellung und Anwendung
DE69704833T2 (de) Derivate der thiazolidine-4-carbonsäure als cytoprotektive mittel
DE69104948T2 (de) Spiro[4,5]decanderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
EP0010156B1 (de) 6-Arylpyridazin-3-one, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung
DE2602643A1 (de) 1,2-benzisothiazolinone-3, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
EP0029247A1 (de) Alkenyl-thienyl-alkancarbonsäuren und ihre Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE69329618T2 (de) 3-oxo-1,4-benzothiazin-derivate
DE69500274T2 (de) Thiazin- oder Thiomorpholinderivate
EP0030632B1 (de) Benzothiazolderivate, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung
DE69417523T2 (de) 3-Oxo-1,4-Benzothiazinderivate
DE2812353A1 (de) Oxazol- und thiazol-alkansaeureverbindungen, verfahren zu ihrer herstellung und sie enthaltendes pharmazeutisches mittel
DE69414396T2 (de) Acylphenylglycin-derivat und dieses als aktivbestandteil enthaltendes vorbeugungs -und heilmittel gegen durch erhöhte collagenaseaktivität verursachte krankheiten
DE69515498T2 (de) Naphthyridinderivate
EP0242767A2 (de) N-dihydroindolylethylsulfonamide
DE69113338T2 (de) Pyranobenzoxadiazolderivate.
JPH05507272A (ja) ３―（３―アルキルチオプロピル）ベンゾチアゾリン誘導体、その製造およびそれを含有している医薬用生成物
DE3104785A1 (de) Basische ether der 4-hydroxy-benzophenone, die als (beta)-blocker wirksam sind, und verfahren zu ihrer herstellung
DE69018741T2 (de) Konjugierte gamma-Hydroxybutenolid-Derivate und sie als aktiver Wirkstoff enthaltende Mittel gegen Magengeschwüre.
EP0543201A2 (de) Alkoxylierte Phenyl- und Cumarinderivate, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln gegen Virusinfektionen
EP0125684B1 (de) 2-Alkylthio-1-aminoalkyl-2-pyrrolin-3-carbonitrile, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel für die Prophylaxe und Therapie thrombotischer Zustände
JP2964380B2 (ja) 新規３−オキソ−１，４−ベンゾチアジン誘導体

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee